Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections

Intranasal administration of neomycin sulfate in murine models shows promise as a prophylactic and therapeutic agent against respiratory viruses like influenza A and SARS-CoV-2 by inducing interferon-stimulated gene (ISG) expression, independent of microbiota and interferon activation.

Study sheds light on the promising role of virtual reality in treating depression

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).

May 6, 2024

Study shows reduced coronary artery calcification with closer access to green and blue spaces

The effects of socioeconomic position and race on the link between closeness to urban green and blue areas and cardiovascular health.

July 2, 2024

GSK shrinks Scynexis deal after delay in commercialization of antifungal drug

Scynexis will get less money in a multimillion-dollar license agreement with GlaxoSmithKline after potential cross-contamination in the manufacturing of its antifungal drug delayed commercialization. Scynexis

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.